comparemela.com

Page 18 - Carl Heilman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CereVasc Appoints Dr Adel Malek Chief Medical Officer

BOSTON, March 28, 2023 /PRNewswire/ CereVasc, Inc., a privately held, clinical-stage, medical device company developing novel, minimally invasi.

San franciscoUnited statesTufts medical centerMassachusetts institute of technologyDan levangieAdel malekCarl heilmanCerevasc incUniversity of californiaNeurosurgery at tufts medical centerPrnewswire cerevasc incEndovascular divisionCompany contactHarvard medical schoolChief medicalNeurovascular surgery

Yale Neurosurgeons Implant First Endovascular Device for Hydrocephalus in North America

A leading expert in neuroendovascular surgery, Charles Matouk, MD, and his team at Yale School of Medicine are now paving the way for better treatments for

Yale new haven hospitalUnited statesCarl heilmanAdel malekCharles matoukUniversity of torontoYale school of medicineYale schoolNeurovascular surgeryNormal pressure hydrocephalusMount sinai

Conservation group, municipality sue to block Lake George herbicide use

The Lake George Association and the Town of Hague filed suit against state agencies in a bid to block the planned use of an aquatic herbicide

Dave wickZachary matsonChris navitskyWarren county supreme courtDepartment of environmental conservationAdirondack park agencyLake george associationLake george park commissionProspect mountainLake georgeCarl heilmanEnvironmental conservationLake minerva

First patient treated in CereVasc® clinical trial of eShunt® System for Normal Pressure Hydrocephalus

Press release content from PR Newswire. The AP news staff was not involved in its creation.

United statesBuenos airesDistrito federalSagrada familiaTufts medical centerDan levangieClinica sagrada familiaCarl heilmanLas neurocienciasPedro lylykAdel malekCompany contactUniversity of buenos airesWorld stroke organizationFounder of the cerebrovascular researchHydrocephalus association

First patient treated in CereVasc® clinical trial of eShunt® System for Normal Pressure Hydrocephalus

Clinical trial underway in Argentina to study minimally invasive treatment for NPHBOSTON, April 25, 2022 /PRNewswire/ CereVasc, Inc., a private.

United statesBuenos airesDistrito federalSagrada familiaTufts medical centerDan levangieClinica sagrada familiaCarl heilmanLas neurocienciasPedro lylykAdel malekNational stroke prevention campaignCompany contactArgentine stroke associationUniversity of buenos airesWorld stroke organization

vimarsana © 2020. All Rights Reserved.